IGF-I (human), (recombinant) | Enzo Life Sciences ADI-908-059-0100 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Enzo Life Sciences

other brands :

Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis

product type :

protein

product name :

IGF-I (human), (recombinant)

catalog :

ADI-908-059-0100

quantity :

100 µg

product information

Product ID :

ADI-908-059

Catalog Number :

ADI-908-059-0100

Product Name :

IGF-I (human), (recombinant)

Product Type :

Protein

Size :

100 µg

Background :

Insulin-like growth factor-1 (IGF-1) was originally known as Somatomedin C but was later changed to IGF-1 due to its structural similarity to proinsulin. IGF-1 has insulinlike effects, but it appears to be involved in many other functions and has been linked to aging, nutrition, physical activity and cancer. While each of these is very interesting on its own, together they may shed light on the role that lifestyle plays in influencing cancer risk. High levels of circulating IGF-1 and low levels of IGF binding protein-3 (IGFBP-3) are associated with increased risk of several cancers. IGF-1 can stimulate cell proliferation and inhibit apoptosis in many differe nt kinds of cells. IGF-1 circulates in blood bound with IGFBPs. Six IGFBPs have been identified but the majority of circulating IGF -1 is complexed with IGFBP-3. The IGF-1 and IGFBP-3 exist in a complex with a third protein, named the acid -labile subunit.

ALTnames :

Insulin-like growth factor I

Purity :

≥98% (SDS-PAGE; RP-HPLC)

Buffer :

Lyophilized. Sterile filtered freeze-dried powder after extensive dialysis against 50mM acetic acid.

Uses :

Western blot control.

Application Summary :

ELISA, WB, Activity assay

Storage :

-20°C